Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT07191756
Eligibility Criteria:
Inclusion Criteria:
1. Confirmed diagnosis of mucormycosis based on histopathology, culture, or typical radiographic findings in accordance with established guidelines.
2. Received primary antifungal treatment for mucormycosis with either amphotericin B (any formulation) or isavuconazole for at least 48 hours.
3. Had at least one follow-up assessment after initiation of antifungal therapy to evaluate treatment response.
4. Medical records from the participating hospitals are sufficiently complete for data extraction regarding treatment and outcomes.
Exclusion Criteria:
* Patients who were not treated with amphotericin B or isavuconazole; and patients who did not have mucormycosis.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07191756
Study Brief:
Protocol Section:
NCT07191756